Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL18173573 | 0.96 | AOC3 (0.60) | AOC3RAB9A | |
| Sulfuric Acid SCHEMBL18173563 | 0.95 | AOC3 (0.59) | AOC3RAB9A | |
| SCHEMBL1973686 | 0.94 | AOC3 (0.65) | AOC3RAB9A | |
| SCHEMBL12094922 | 0.94 | AOC3 (0.65) | AOC3RAB9A | |
| Hydrochloric Acid SCHEMBL18173566 | 0.92 | AOC3 (0.64) | AOC3RAB9A | |
| SCHEMBL18953107 | 0.83 | AOC3 (0.62) | AOC3 | |
| SCHEMBL11516578 | 0.82 | AOC3 (0.58) | AOC3RAB9A | |
| SCHEMBL28563810 | 0.79 | AOC3 (0.66) | AOC3 | |
| SCHEMBL28563808 | 0.79 | AOC3 (0.66) | AOC3 | |
| SCHEMBL11514454 | 0.78 | AOC3 (0.53) | AOC3RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3286189-B1 | CRYSTALLINE MESYLATE SALT AS SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME INHIBITOR | BENEVOLENTAI CAMBRIDGE LTD (GB) | 2021-05-26 | — | — | EP | claimed |
| EP-3286190-B1 | PHARMACEUTICAL SALT FORMS OF AN INHIBITOR OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) | BENEVOLENTAI CAMBRIDGE LTD (GB) | 2020-06-03 | — | — | EP | claimed |
| US-10369139-B2 | Crystalline compound as semicarbazide-sensitive amine oxidase (SSAO) enzyme inhibitor | Benevolentai Cambridge Limited (GB) | 2019-08-06 | — | — | US | claimed |
| US-20180111928-A1 | PHARMACEUTICAL SALT FORMS OF AN INHIBITOR OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) | PROXIMAGEN LIMITED (GB) | 2018-04-26 | — | — | US | claimed |
| US-20180085357-A1 | CRYSTALLINE COMPOUND AS SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME INHIBITOR | PROXIMAGEN LIMITED (GB) | 2018-03-29 | — | — | US | claimed |
| EP-3286189-A1 | CRYSTALLINE COMPOUND AS SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME INHIBITOR | Proximagen Limited (GB) | 2018-02-28 | — | — | EP | claimed |
| EP-3286190-A1 | PHARMACEUTICAL SALT FORMS OF AN INHIBITOR OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) | Proximagen Limited (GB) | 2018-02-28 | — | — | EP | claimed |
| WO-2016170351-A1 | PHARMACEUTICAL SALT FORMS OF AN INHIBITOR OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) | PROXIMAGEN LIMITED (GB) | 2016-10-27 | — | — | WO | claimed |
| WO-2016170352-A1 | CRYSTALLINE COMPOUND AS SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME INHIBITOR | PROXIMAGEN LIMITED (GB) | 2016-10-27 | — | — | WO | claimed |
| EP-3286189-B1 | CRYSTALLINE MESYLATE SALT AS SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME INHIBITOR | BENEVOLENTAI CAMBRIDGE LTD (GB) | 2021-05-26 | — | — | EP | disclosed |
| EP-3777846-A1 | VAP-1 INHIBITORS FOR TREATING PAIN | BenevolentAI Cambridge Limited (GB) | 2021-02-17 | — | — | EP | disclosed |
| US-20200397764-A1 | VAP-1 INHIBITORS FOR TREATING PAIN | PROXIMAGEN, LLC | 2020-12-24 | — | — | US | disclosed |
| EP-3286190-B1 | PHARMACEUTICAL SALT FORMS OF AN INHIBITOR OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) | BENEVOLENTAI CAMBRIDGE LTD (GB) | 2020-06-03 | — | — | EP | disclosed |
| US-10369139-B2 | Crystalline compound as semicarbazide-sensitive amine oxidase (SSAO) enzyme inhibitor | Benevolentai Cambridge Limited (GB) | 2019-08-06 | — | — | US | disclosed |
| EP-3286190-A1 | PHARMACEUTICAL SALT FORMS OF AN INHIBITOR OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) | Proximagen Limited (GB) | 2018-02-28 | — | — | EP | disclosed |
| EP-3285767-A1 | TREATMENT OF PAIN | Proximagen Limited (GB) | 2018-02-28 | — | — | EP | disclosed |
| WO-2017098236-A1 | VAP-1 INHIBITORS FOR TREATING PAIN | PROXIMAGEN LIMITED (GB) | 2017-06-15 | — | — | WO | disclosed |
| WO-2016170353-A1 | TREATMENT OF PAIN | PROXIMAGEN LIMITED (GB) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016170351-A1 | PHARMACEUTICAL SALT FORMS OF AN INHIBITOR OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) | PROXIMAGEN LIMITED (GB) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016170352-A1 | CRYSTALLINE COMPOUND AS SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME INHIBITOR | PROXIMAGEN LIMITED (GB) | 2016-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200397764-A1 | VAP-1 INHIBITORS FOR TREATING PAIN | VAPB, VAPA, OPRL1 | AOC3 55/4885RAB9A 3287/4885 |
| US-10369139-B2 | Crystalline compound as semicarbazide-sensitive amine oxidase (SSAO) enzyme inhibitor | PNPO, MAOA, AOC3 | AOC3 3/4885RAB9A 4361/4885 |
| US-20180111928-A1 | PHARMACEUTICAL SALT FORMS OF AN INHIBITOR OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) | SMOX, AOC3, DAO | AOC3 2/4885RAB9A 4118/4885 |
| US-20180085357-A1 | CRYSTALLINE COMPOUND AS SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME INHIBITOR | MAOA, PNPO, AOX1 | AOC3 4/4885RAB9A 4377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.